Despite some intraday gains, the price continues to face liquidi
Decoding Next Move To Come From CRO Price
After a significant drop from $1 to $0.048, CRO's price structure showed a remarkable recovery, advancing over 260% to reach a year-to-date high of $0.1800 by March 10th, 2024.
However, these gains proved unsustainable as bearish forces took over, pushing the price back to its original demand zone near $0.073.
Currently, the accumulation of holders offers a glimmer of hope amid various bearish factors, indicating growing uncertainties in CRO's price.
Despite some intraday gains, the price continues to face liquidity issues and struggles near the 20-day EMA band.
For a potential bullish reversal, CRO needs a catalyst to drive higher interest. It is already in a key demand area, but further sell-offs could break this zone, leading to lower support around $0.048.
A decisive Change of Character (ChoCh) above $0.10 and the 200-day EMA would confirm a bullish signal. Until then, uncertainty remains.
Other indicators are flat, reflecting market uncertainties and providing no clear direction.
After a significant drop from $1 to $0.048, CRO's price structure showed a remarkable recovery, advancing over 260% to reach a year-to-date high of $0.1800 by March 10th, 2024.
However, these gains proved unsustainable as bearish forces took over, pushing the price back to its original demand zone near $0.073.
Currently, the accumulation of holders offers a glimmer of hope amid various bearish factors, indicating growing uncertainties in CRO's price.
Despite some intraday gains, the price continues to face liquidity issues and struggles near the 20-day EMA band.
For a potential bullish reversal, CRO needs a catalyst to drive higher interest. It is already in a key demand area, but further sell-offs could break this zone, leading to lower support around $0.048.
A decisive Change of Character (ChoCh) above $0.10 and the 200-day EMA would confirm a bullish signal. Until then, uncertainty remains.
Other indicators are flat, reflecting market uncertainties and providing no clear direction.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.